Travere Therapeutics (TVTX) Goodwill (2014 - 2025)

Travere Therapeutics (TVTX) reported Goodwill of $800000.0 for Q3 2025, little changed on a YoY basis from $800000.0 in Q3 2024, and little changed quarter-over-quarter from $800000.0 in Q2 2025.

Travere Therapeutics (TVTX) Goodwill (2014 - 2025) Analysis & Trends

Travere Therapeutics has reported Goodwill for 12 years, with the latest figure at $800000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Goodwill changed 0.0% year-over-year to $800000.0; the trailing twelve-month figure through Sep 2025 stood at $800000.0 (changed 0.0% YoY), and the FY2024 full-year result was $800000.0, changed 0.0% from the prior year.
  • Goodwill for Q3 2025 stood at $800000.0, roughly flat from $800000.0 in the prior quarter.
  • The five-year high for Goodwill was $936000.0 in Q1 2021, with the low at $800000.0 in Q4 2022.
  • Historically, Goodwill has averaged $853052.6 across 5 years, with a median of $800000.0 in 2022.
  • Annual changes were most pronounced in 2021 — Goodwill changed 0.0% — and 2022, when it slipped 11.11%.
  • Travere Therapeutics' Goodwill stood at $900000.0 in 2021, then retreated by 11.11% to $800000.0 in 2022, then changed by 0.0% to $800000.0 in 2023, then changed by 0.0% to $800000.0 in 2024, then changed by 0.0% to $800000.0 in 2025.
  • The last three Goodwill figures came in at $800000.0 (Q3 2025), $800000.0 (Q2 2025), and $800000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Travere Therapeutics 5.07 Bn 4.99 Bn 102.38 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 800,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 800,000.00
Dec 31, 2024 800,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Mar 31, 2024 800,000.00
Dec 31, 2023 800,000.00
Sep 30, 2023 800,000.00
Jun 30, 2023 900,000.00
Mar 31, 2023 900,000.00
Dec 31, 2022 800,000.00
Sep 30, 2022 900,000.00
Jun 30, 2022 900,000.00
Mar 31, 2022 900,000.00
Dec 31, 2021 900,000.00
Sep 30, 2021 936,000.00
Jun 30, 2021 936,000.00
Mar 31, 2021 936,000.00
Dec 31, 2020 900,000.00